You are here: Industry Insights > AI

News List

Merck KGaA links with AI firm to iron out side-effects during R&D pharmaphorum
December 11, 2018
Germany’s Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) to uncover new drug targets and predict any side effects.
Merck partners with Cyclica for AI-based screening of drug targets pharmaceutical-technology
December 11, 2018
Merck has signed an agreement to licence Canadian Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts......
AI app decreases symptoms of COPD, study finds pharmatimes
December 11, 2018
A new clinical study has found that Kaia Health’s artificial intelligence app successfully decreases symptoms of Chronic Obstructive Pulmonary Disease (COPD).
New AI tech could outperform humans in medical imaging pharmaphorum
December 10, 2018
Tech firm Cambridge Consultants has announced a new Artificial Intelligence (AI) technology that can produce more accurate medical imaging by creating clear.....
Awards for AI-based drug R&D continue for second year pharmaphorum
December 10, 2018
UK health technology firm BenevolentAI and the Association of Medical Research Charities are continuing an award encouraging use of artificial intelligence (AI) to develop new therapies for a second year.
UCB to invest £1 billion into UK R&D pharmafile
December 10, 2018
The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector Deal, which details public and private sector
C4XD forms discovery partnership with AI company GTN pharmatimes
November 30, 2018
The partnership aims to maximise insights from shape-based chemistry, and generate novel drug candidates in neurodegeneration.
Exscientia builds AI capability with Kinetic acquisition pharmaphorum
November 27, 2018
There is huge focus on the potential of artificial intelligence (AI) in drug discovery – and Exscientia is another UK company building its capability in this area.
AI could help to reduce gadolinium dose in MRI europeanpharmaceuticalreview
November 27, 2018
Articifial intelligence has been used to administer lower doses of gadolinium, a contrast agent often left in the body after magnetic resonance imaging…
Big Data and AI provide better diagnosis and treatment europeanpharmaceuticalreview
November 27, 2018
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page